Prostate Treatments: What Every Man Should Know
A host of prostate treatments options are now available for men who suffer from conditions such as prostatitis, enlarged prostate and even cancer. Medicines, surgical procedures, radiation cure, complementary therapies and supplements for maintaining prostrate gland health are available to help alleviate the symptoms suffered from by patients.
In choosing prostate treatments, a patient should first discuss thoroughly with his physician the various options to understand the pros and cons of using a particular medication or therapy. For men, particularly those aged 45 and above, maintaining a healthy prostate is necessary. The escalating number of men suffering from prostate cancer, BPH and prostatitis has awakened the medical community to the need to develop treatment options to address these conditions.
For enlarged prostate or benign prostatic hypertrophy (BPH), the most commonly used medications are alpha blockers and finasteride or dutasteride. Terazosin, prazosin and doxazosin are alpha blockers that have been approved for use in treating BPH. For advanced cases of this condition, surgical procedures such as transurethral resection, transurethral incision and transurethral microwave thermotherapy have been made available.
For prostatitis, the first line of treatment is usually antibiotics. The most commonly used antibiotics in treating this condition is Ciprofloxacin. Alpha blockers such as tamsulosin and alfuzosin may also be used. Another popular medication for treating prostatitis is Quercetin, a bioflavonoid that helps decrease inflammation in the prostate gland. Cernilton and the immunomodulator called suplatast tosilate have also been found to be effective against prostatitis.
For prostate cancer patients, several options are available to help them manage and treat their condition. For older men and those who have other serious diseases, watchful waiting is usually the recommended option. In cases when the cancer has gone beyond Stage I, more aggressive treatment strategies are recommended such as surgery, radiation therapy, cryosurgery and chemotherapy. Hormone therapy is also sometimes used to supplement regular treatment methods, particularly in the more developed stages.
A host of prostate treatments have been developed by scientists to fit almost all levels and types of prostate gland disorders. But before choosing a treatment strategy, men should first consult with their doctors and discuss in detail the pros and cons of each of these options.
The only product we can really recommend since it is the only product we know of that actually has shown to reduce prostate size while promoting prostate health is Prostacet
Some of it's benefits are:
- Support positive hormone balance
- Promote good circulation within prostate tissue
- Provide antioxidant support for prostate tissue
- Inhibit inflammation within the prostate
- Support healthy immune function
Click here for more information on Prostacet
Here we provide you with a list of pages that contain links to all our articles. Check them out!
'Common ancestor cell' identified
A landmark genetic study exposing the roots of advanced prostate cancer in 10 men has uncovered a potential Achilles heel that could lead to new personalised treatments.
Study on new treatment for prostate cancer
A new study represents the first time low temperature plasmas (LTPs) have been applied on cells grown directly from patient tissue samples. Taking both healthy prostate cells and prostate cancer tissue cells from a single patient, the study allowed for direct comparison of the effectiveness of the treatment. Scientists discovered that LTPs may be a potential option for treatment of patients with ...
Charity Apple raising awareness of prostate cancer in Redbridge
But although in many cases they will be suffering from minor illnesses, sometimes the problems are indicative of a serious condition. Prostate cancer is one of the biggest killers of men, a disease which is often symptomless in the beginning.
Prostate cancer treatment to be funded from 1 May
PHARMAC will begin funding for the prostate cancer treatment abiraterone (Zytiga) from 1 May 2015, potentially benefiting up to 1000 men annually.
Detecting cancer cells in blood can give an early warning of treatment failure
( Institute of Cancer Research ) A blood test that measures the number of cells shed from prostate tumors into the bloodstream can act as an early warning sign that treatment is not working, a major new study shows.Researchers showed that measuring the numbers of circulating tumor cells in the blood predicted which men were benefiting least from a prostate cancer drug after as little as 12 weeks ...